Understanding ALS: new therapeutic approaches
- PMID: 23217177
- DOI: 10.1111/febs.12087
Understanding ALS: new therapeutic approaches
Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease associated with motor neuron degeneration, muscle atrophy and paralysis. Although numerous pathological mechanisms have been elucidated, ALS remains an invariably fatal disease in the absence of any effective therapy. The heterogeneity of the disease and the failure to develop satisfactory therapeutic protocols reinforce the view that ALS is a multi-factorial and multi-systemic disease. Thus, a better understanding of the pathogenic mechanisms and study of the potential pathological relationship between the various cellular processes is required to ensure efficacious therapy. The pathogenic mechanisms associated with ALS are reviewed, and the strengths and limitations of some new therapeutic approaches are discussed.
Keywords: ALS-associated genes; amyotrophic lateral sclerosis; complexity of ALS pathogenesis; growth factors; mutant SOD1 toxicity; neuromuscular disease; oxidative stress; skeletal muscle; stem cells; therapeutic approaches.
© 2012 The Author Journal compilation © 2012 FEBS.
Similar articles
-
Cellular and molecular approaches to motor neuron therapy in amyotrophic lateral sclerosis and spinal muscular atrophy.Neurosci Lett. 2012 Oct 11;527(2):78-84. doi: 10.1016/j.neulet.2012.04.079. Epub 2012 May 8. Neurosci Lett. 2012. PMID: 22579818 Review.
-
Therapeutic progress in amyotrophic lateral sclerosis-beginning to learning.Eur J Med Chem. 2016 Oct 4;121:903-917. doi: 10.1016/j.ejmech.2016.06.017. Epub 2016 Jun 14. Eur J Med Chem. 2016. PMID: 27372371 Review.
-
[Pathogenesis and therapeutic perspectives for amyotrophic lateral sclerosis (ALS)].Rinsho Shinkeigaku. 2007 Nov;47(11):790-4. Rinsho Shinkeigaku. 2007. PMID: 18210800 Japanese.
-
New therapy options for amyotrophic lateral sclerosis.Expert Opin Pharmacother. 2013 Oct;14(14):1907-17. doi: 10.1517/14656566.2013.819344. Epub 2013 Jul 16. Expert Opin Pharmacother. 2013. PMID: 23855817 Review.
-
Gene therapy for amyotrophic lateral sclerosis.Neurobiol Dis. 2012 Nov;48(2):236-42. doi: 10.1016/j.nbd.2011.08.018. Epub 2011 Aug 25. Neurobiol Dis. 2012. PMID: 21889591 Review.
Cited by
-
The Role of Small Heat Shock Proteins in Protein Misfolding Associated Motoneuron Diseases.Int J Mol Sci. 2022 Oct 4;23(19):11759. doi: 10.3390/ijms231911759. Int J Mol Sci. 2022. PMID: 36233058 Free PMC article. Review.
-
The Biogenesis of miRNAs and Their Role in the Development of Amyotrophic Lateral Sclerosis.Cells. 2022 Feb 7;11(3):572. doi: 10.3390/cells11030572. Cells. 2022. PMID: 35159383 Free PMC article. Review.
-
Neuromuscular Junction as an Entity of Nerve-Muscle Communication.Cells. 2019 Aug 16;8(8):906. doi: 10.3390/cells8080906. Cells. 2019. PMID: 31426366 Free PMC article. Review.
-
Tdp-25 Routing to Autophagy and Proteasome Ameliorates its Aggregation in Amyotrophic Lateral Sclerosis Target Cells.Sci Rep. 2018 Aug 17;8(1):12390. doi: 10.1038/s41598-018-29658-2. Sci Rep. 2018. PMID: 30120266 Free PMC article.
-
VAPB ER-Aggregates, A Possible New Biomarker in ALS Pathology.Cells. 2020 Jan 9;9(1):164. doi: 10.3390/cells9010164. Cells. 2020. PMID: 31936602 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous